⚠️ Small Study / Early Comparative Evidence
Researchers compared fecal microbiota from 29 patients with SUDD, 35 symptomatic patients without SUDD, and 68 asymptomatic controls. The study evaluated microbial diversity, taxonomic abundance, and predicted functional pathways.
Clinical Considerations
- SUDD showed greater abundance of the Ruminococcus gnavus group and reduced Coprococcus compared with both reference groups.
- Microbial diversity was lower in both symptomatic groups than controls, limiting specificity for SUDD.
- PICRUSt2 identified predicted pathway differences but did not directly measure microbial gene expression, metabolites, or epithelial function.
- Cross-sectional design, sample loss, separate control recruitment, and single-country enrollment limit causal and population-level interpretation.
Practice Applications
- Recognize microbiome findings as associations rather than diagnostic markers or treatment targets.
- Interpret SUDD using established clinical criteria and exclusion of competing gastrointestinal conditions.
- Avoid recommending probiotics, dietary changes, or microbiome-directed therapies based on these findings.
- Monitor longitudinal research incorporating metagenomic, transcriptomic, and metabolomic measurements.
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS